Vitamin A is an important regulator of cell differentiation and function. In its absence, a number of cells in vivo undergo squamous metaplasia (Wolbach & Howe, 1925) which in the case of mouse prostate in vitro may be reversed by vitamin A (Laznitski, 1963) . This type of cell transformation is though to indicate neoplastic potential, a situation clearly evident in the vitamin A deficient rat where a higher rate of spontaneous carcinomas is detected (Fujimaki, 1926) .
There is evidence to suggest that vitamin A (retinol) may mediate its biological actions through cellular retinol binding protein (cRBP) which binds the ligand specifically and with high affinity (Ong & Chytil, 1975 , 1978 . cRBP may serve to deliver retinol from the cytoplasm to nuclear acceptor sites where it affects genetic read out (Liau et al., 1981) .
The presence of cRBP in human (benign) hyperplastic prostate (BPH) has been reported by this laboratory (Boyd et al., 1984) . The protein binds retinol with high affinity (35nM) and shows similar characteristics to the component analysed in other tissues (Bashor et al., 1973) .
Reports from several laboratories suggest that the expression of cRBP in malignancy may be altered. In this respect, examination of epidermoid carcinomas of the oral cavity and oropharynx revealed cRBP levels to be higher in the malignancy than in normal adjacent tissue (Ong et al., 1982) . In another study (Palan & Romney, 1980) reduced levels of cRBP were reported in a number of human tumours including lungs, ovaries and endometrium. However, to the knowledge of these workers, no study has yet been undertaken to compare cRBP levels in human hyperplastic and malignant prostate (CaP) .
In was checked for purity every two weeks as described previously (Boyd et al., 1984) . All transretinol (unlabelled ) was obtained from Sigma Chemicals, Poole, Dorset, UK. All retinoids were stored in ethanol solution, under nitrogen, in the dark at -20°C. Other chemicals were of analytical grade and obtained from Sigma, BDH, Poole, Dorset, UK or Fisons, Leicester, UK. The following buffers were used in these studies; TEDG containing Tris 10 mM, EDTA 1.5 mM, dithiothreitol 1.0mM, glycerol 10% (v/v) pH 7.4; DCC containing dextran 0.025%, gelatin 0.1%, activated charcoal 0.25% (w/v) in TED pH 7.4 buffer.
The patients entered in the present study were in the age range 50-70 years. None of the cancer patients had received any therapy (endocrine, radiation etc.) prior to entry into this study. Prior to the prostatectomy malignant tumours were clinically staged by digital palpation using the TNM system (Harmer, 1978) . Incidental tumours (To) and those clinically staged as T1 were excluded from this study on the grounds that the portion of gland assessed as malignant may be unrepresentative of that selected for scientific work.
Prostate tissues were removed by trans-urethral resection. Large uncharred prostatic chippings were selected for our biochemical studies and transported to the laboratory in ice-cold saline (0.9% w/v). A portion of each chipping was retained for histological analysis and assigned a Gleason Score (Gleason, 1966) by the pathologist. Specimens used for biochemical studies were snap frozen in liquid nitrogen and stored at -70°C until required for further analysis. In this study, a total of 16 hyperplastic and 15 malignant glands were assessed for retinol binding.
The following procedures were carried out at 4°C. Prostate tissue (0.5-2.0g) was finely minced with scissors and pulverised for 20sec in a Teflon vial pre-cooled at -20°C using a Mikrodismembrator II (B. Braun, Melsungen AG, FRG). The tissue was homogenised in 5-10 vol of TEDG buffer as described previously (Boyd et al., 1984) and ultracentrifuged at 100,000g for 1 h to obtain the cytosol fraction.
The retinol binding assay for cRBP was as described previously (Boyd et al., 1984) After incubation with radio-ligand, cytosol was treated with charcoal pellets (Boyd et al., 1984) to remove unbound ligand, and finally counted for radioactivity in 6 ml of scintillation cocktail.
Non specific binding was corrected for, by subtracting the radioactivity bound in the presence of unlabelled retinol from that observed in the absence of competitor. Control experiments had shown that charcoal treatment removed over 99.5% of free [3H]retinol from buffer and that remaining radioactivity in no way interfered with the measurement of prostate cRBP.
Cytosol protein was assayed by the method of Bradford (1976) using BSA as standard. The difference in cRBP levels between benign and malignant prostates was tested for statistical significance by the Mann-Whitney U-test.
Hyperplastic prostate cytosol bound an average of 4.0+1.6 pmol of [3H]retinol per mg of protein (Figure 1) (range: 1.9-8.4 pmol ml-protein). In contrast less retinol (1.7+1.6pmolmg-1; range: 0-6.5pmolmg-t protein) was specifically bound by the malignant gland. In spite of an overlap between the two groups there was a statistically significant difference between the levels of cRBP in BPH and CaP (P <0.01). Although all benign prostates asayed for cRBP were found to be positive, this was not the case in malignancy where 3/15 glands were devoid of retinol binding, or at least below the detection limits of the assay (100 fmol mg-1).
In contrast to the differences observed between BPH and CaP, these workers could find no relationship between the levels of cRBP and histological differentiation. In fact, similar amounts of [3H]retinol were bound in well (Gleason sum 3-4; 1.0+0.3pmolmg-1) and poorly differentiated (Gleason sum 7-8; 1.1 ± 1.5 pmol mg -1) tumours.
Data presented in this report suggest that malignant prostate has a decreased ability to bind retinol when compared with the benign, hyperplastic gland. Suppressed retinol binding was also found in a number of other human malignancies including lung, ovarian and breast as reported by Palan & Romney (1980) . These data (Hall et al., 1973) or masked as cellular retinoic acid binding protein is in anaplastic breast cancer.
I
In view of the reduced levels of cRBP in malignant tissue compared to BPH, it was surprising not to find any correlation between the levels of these binding sites and the histological differentiation of the tumour. Similar observations were made by Mehta et al. (1982) when investigating retinoic acid binding in human breast cancer.
The aetiological significance of these findings with regard to prostate malignancy can only be speculated on. Perhaps noteworthy is that such changes do not necessarily infer a particular requirement by the malignant cell for vitamin A (Abelev, 1971) . On the other hand, the possibility exists that these data may be of prognostic significance. In this regard low retinol binding in patients with BPH could be used to identify those, who, in time would progress to malignancy.
